← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2012-05-22

Drug application

FDA Application #

ANDA202523

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEVIRAPINE

Generic name

NEVIRAPINE

Active ingredients

NEVIRAPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN PHARMS INC

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2012-05-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown